Amyris Finalizes Cannabinoid Development, Licensing and Commercialization Agreement Containing $300 Million of R&D and Milestone Payments and a Long-Term Royalty Stream
Nature Publishing Group Study Highlights Potential of Indee Labs Technology as an Alternative to Current Gene-Modified Cell Therapy Manufacturing
Beam Therapeutics Secures $135 Million in Series B Financing to Advance Base Editing Platform and Expand Pipeline of Precision Genetic Medicines
Can synthetic biology help Vanderbilt University Medical Center researchers develop therapeutic antibodies in only 90 days?
Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance
Codexis Secures Multi-Year Technology Upgrade Package for its CodeEvolver Protein Engineering Platform License with Merck
Renaissance BioScience Corp. partners with Mitacs in a million-dollar project to test precision yeast-based RNAi technologies for environmentally friendly agricultural biopesticides and medical biotherapeutics
